Pages that link to "Q34378724"

The following pages link to Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study (Q34378724):

Displaying 17 items.

• Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies (Q21146666) (← links)
• Luteal phase support for assisted reproduction cycles (Q24186532) (← links)
• Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data (Q26768705) (← links)
• Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials (Q28550893) (← links)
• A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization (Q33589647) (← links)
• A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization (Q34181515) (← links)
• Pharmaceutical and clinical development of a novel progesterone formulation. (Q34492644) (← links)
• Progesterone and the luteal phase: a requisite to reproduction (Q35621181) (← links)
• Has ART Finally Got a Patient-Friendly Progesterone? (Q36083776) (← links)
• Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue? (Q36301761) (← links)
• Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials. (Q38636055) (← links)
• Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization-embryo transfer: patient preference and drug efficacy (Q46973010) (← links)
• Phase III trial of 8% vaginal progesterone gel for luteal phase support in Japanese women undergoing in vitro fertilization and fresh embryo transfer cycles (Q47099104) (← links)
• Use of progesterone in female reproduction: tradition and trends (Q50963046) (← links)
• Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial (Q57284013) (← links)
• Progesterone loaded thermosensitive hydrogel for vaginal application: Formulation and in vitro comparison with commercial product (Q92307058) (← links)
• Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome (Q92515311) (← links)